News for 2008
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent agency funded by Canadian federal, provincial, and territorial governments to provide health care decision makers with credible, impartial advice and information about the effectiveness and efficiency of drugs and other health technologies. Unlike regulators who determine which technologies can be used in Canada, CADTH supports decision makers who are exploring what technologies should be used to achieve the best outcomes both on patient health and the health care system.
For details on how to contact CADTH, visit our Contact Us page.
CDR Consultations — December 2008
December 09, 2008
Brian O’Rourke Appointed Vice-President, Common Drug Review
November 17, 2008
The Canadian Agency for Drugs and Technologies in Health (CADTH) is pleased to announce the appointment of Brian O’Rourke as Vice-President, Common Drug Review (CDR). He will assume his ...
CADTH featured in Globe and Mail Diabetes Awareness supplement
November 12, 2008
Globe and Mail Diabetes Awareness supplement
Hip Protectors in Long-Term Care: A Clinical and Cost-Effectiveness Review and Primary Economic Evaluation
September 30, 2008
CADTH’s rapid health technology assessment on hip protectors in long-term care examines the clinical effectiveness and the cost-effectiveness of using hip protectors to prevent fractures ...
CADTH welcomes Federal Government response to Standing Committee on Health report on the Common Drug Review
April 10, 2008
OTTAWA — The Canadian Agency for Drugs and Technologies in Health (CADTH) gratefully acknowledges the Government of Canada’s support and recognition of the vital role of the Common ...
Interview with the Canadian Society of Telehealth (CST) on CADTH's Telestroke report
February 15, 2008
February 15, 2008 CST's Vice President Dr. Trevor Cradduck interviews Don Husereau, Director of HTA Development at CADTH -- The topic: CADTH's newly released report on ...